Findings of the simulation study were additionally confirmed by a real data set investigating the association between methotrexate clearance and the SLCO1B1 gene in patients with acute lymphoblastic leukemia. The gene discussed is SLCO1B1; the disease is acute lymphoblastic leukemia.